Table 1. Time frame of disease recurrence/residual disease.
Follow-up period | Number of patients with no residual disease at site of ablation | Number of deaths | Number of patients—loss to follow-up |
---|---|---|---|
1-month | 15/17 (88%) | 0 | 0 |
3-month | 12/17 (71%) | 3 | 0 |
6-month | 11/17 (65%) | 0 | 1 |
1-year | 7/17 (41%) | 1 | 2 |
Demonstrates time frame at which residual disease developed. Table also provides information regarding number of deaths and number of patients who were lost to follow-up at each time interval.